• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Pain Management, Drug Diversion & Controlled Substance Best Practices: A Requirement for West Virginia Pharmacists -WV APPROVED-

Program Type

Monograph

Credits

3 Contact Hour(s)

Release Date

Saturday, April 22, 2017

Offline Date:

Wednesday, April 22, 2020

ACPE Expiration Date

Wednesday, April 22, 2020

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$21.00

  • Overview

    We live in an "Opioid Epidemic" where someone dies approximately every 15 minutes from prescription drug overdose. So just how do we end this "Opioid Epidemic" or at least, how do we as healthcare professionals contribute to the progress of society in the right direction? In this monograph, we will review overall pain management etiology, specific opioid medication pharmacological concepts, opioid overdose reversal treatments, and not only how to identify drug seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. We will also review West Virginia specific controlled substance laws, trends, and the Controlled Substances Monitoring Program. Unlike opioids, this monograph is intended to open one's eyes, elevate blood pressure and/or heart rate, and increase cognition (in relation to the Opioid Epidemic).

     

    This program has been APPROVED for WV Pharmacists to fulfill the requirement of Drug Diversion.  WV-2017-05-10-CE Drug Diversion



    Rating


    Handouts

    Homestudy PDF:   HomestudyPDF17096H04.pdf

    Financial Support By

    PharmCon, Inc.
  • Nurse

    Describe the etiology and epidemiology of chronic pain.
    Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
    Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.
    Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.
    Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
    Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.
    Explain how to be compliant with federal and state controlled substances laws.
    Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
    Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.


    Pharmacist

    Describe the etiology and epidemiology of chronic pain.
    Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
    Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.
    Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.
    Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.
    Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.
    Explain how to be compliant with federal and state controlled substances laws.
    Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
    Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.


    Pharmacy Technician

    Describe the etiology and epidemiology of chronic pain.
    Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.
    Identify the best practices for the use of opioid medications based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; & discontinuation and tapering of opioids.
    Explain how to ensure that the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment are in place within a pharmacy practice
    Describe the best practices for identifying "red flag" patient drug seeking & diversion behaviors
    Explain the best practices for working with patients, prescribers, law enforcement, and other as appropriate, concerning patients suspected of drug seeking behavior and diversion
    Explain how to be compliant with federal and state controlled substance laws
    Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.
    Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-17-096-H04-N

    Pharmacist 0798-0000-17-096-H04-P

    Pharmacy Technician 0798-0000-17-096-H04-T

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher
Adobe Acrobat Reader


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.